PD 131628
PD 131628 is an antimicrobial agent and active PD 131112 metabolite. PD 131628 is two- to four-fold more active than Ciprofloxacin , inhibiting all strains of Staphylococcus aureus and Streptococcus pneumoniae. PD 131628 is very active against Neisseria spp., Haemophilus influenzae and Moraxella catarrhalis, with MIC90s ranging from 0.004 to 0.008 mg/L[1].
Product Specifications
CAS Number
127967-03-7
UNSPSC
12352005
Target
Bacterial; Drug Metabolite
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Infection
Smiles
O=C(O)C1=CN(C2=C(C1=O)C=C(C(N3C[C@H](CC3)N)=N2)F)C4CC4
Molecular Formula
C16H17FN4O3
Molecular Weight
332.33
References & Citations
[1]Cooper MA, et al. In-vitro activity of PD 131628, a new quinolone antimicrobial agent. J Antimicrob Chemother. 1992 May;29 (5) :519-27.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Human IgG Immunoglobulin (IG266), CF488A conjugate, 0.1mg/mL
CD81 / TAPA-1 (1.3.3.22), CF594 conjugate, 0.1mg/mL
